Is Your Leadership Team Built for the Next Phase of the Company?

For nearly two years, much of the life sciences industry operated in survival mode. Capital was tight, financing windows were limited, and leadership teams focused on preserving runway. Hiring slowed dramatically, and many organizations learned to operate with extremely lean teams.

However, the environment is beginning to shift.

Capital markets have loosened. Companies are raising money again. M&A activity is picking up. Public market valuations, while still selective, are healthier than they were during the downturn.

As conditions improve, leadership conversations inside many companies are starting to change. Because the reality is that the leadership team that carries a company through a difficult market cycle isn’t always the same team that takes it into the next phase of growth.

Increasingly, boards and management teams are asking a simple question:

Is the team that got us through the last few years the right team for what comes next?

When the Next Phase Requires a Different Leadership Team

Leadership teams that carried companies through the downturn often did exactly what was required. They managed capital carefully, stayed focused on key programs, and kept the organization moving during a challenging market cycle.

But as companies move into their next stage of growth, expectations evolve.

Different phases of a company’s lifecycle require different leadership strengths. The team that takes a company from early development to its first meaningful milestones may not always be the same team that scales the organization through commercialization, global expansion, or larger capital raises.

In practical terms, the leadership team of a company with a $50 million market cap is not always the same team that’s right for a $250 million market cap and beyond.

That’s not a reflection of performance. It’s simply how companies evolve.

What Typically Drives Leadership Hiring Conversations

Hiring rarely happens in isolation. More often, it follows meaningful changes inside the company.

A new financing round may allow management teams to build roles that were previously deferred. Upcoming data readouts can prompt early discussions around commercialization. We’re already seeing more of that in 2026, with companies beginning to build out commercial teams earlier than they might have in the past.

As companies grow, the demands on finance, clinical, regulatory, and commercial leadership naturally increase.

In each case, leadership needs evolve alongside the company.

Why Timing Matters

One pattern we see consistently is that many companies start leadership hiring discussions later than they should.

Often, those conversations begin only once the need becomes urgent.

But leadership transitions benefit from time and thoughtful planning. The strongest outcomes happen when boards and management teams begin evaluating leadership needs earlier, rather than reacting once pressure builds.

Starting those conversations early allows companies to step back and think more strategically about how their leadership team should evolve.

A Leadership Reset Across the Industry

What we are seeing today is less of a hiring surge and more of a natural leadership reset. Companies that spent the past two years operating in a difficult financing environment are now entering a new phase. Capital is moving again, expectations around growth are rising, and leadership teams are being asked to deliver at a different scale.

For some, the existing team is exactly right for that next phase. For others, it may mean stepping back and evaluating whether the current structure still aligns with where the business is going.

These aren’t always easy conversations. But they’re happening more often—and the companies that start them earlier tend to move forward with a lot more clarity than the ones that wait.

Zach Charles | Managing Partner